HIV-1 genetic diversity is higher in vaginal tract than in blood during early infection
New evidence supports the existence of genetic 'sieve' on the path from vaginal tract to bloodstream...
List view / Grid view
New evidence supports the existence of genetic 'sieve' on the path from vaginal tract to bloodstream...
Researchers have outlined a pioneering method of screening a person’s diverse set of antibodies for rapid therapeutic discovery.
A team of researchers have tested a chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose...
Researchers from Canada try a new approach to eliminate dormant HIV-infected cells from the body using the MG1 virus.
CXCR7 receptor identified as a potential therapeutic target for controlling multiple sclerosis, Parkinson's and AIDS...
Researchers have developed a vaccine candidate that spurs animals to produce antibodies against protective sugars of multiple HIV strains...
Didehydro-Cortistatin A effectively suppresses production of the HIV virus in chronically infected cells and prevents viral rebound...
A human protein A3G inhibits HIV-1 by acting as a roadblock for further replication of the virus...
Scientists have designed a synthetic molecule bryostatin-1 that can reactivate dormant HIV...
A three-pronged antibody has been found to protect from infection with two strains of SHIV, better than individual natural antibodies...
An international team of researchers have demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV..
A new biomedical tool has been developed using nanoparticles that deliver transient gene changes to targeted cells...
Researchers have identified a novel variant "Delta 20" that suppresses the most damaging HIV strains...
Scientists have used a novel live-cell fluorescent imaging system that has allowed them to identify individual particles associated with HIV...
The collaboration will provide MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds.